InsidersTradesSigma
Track the SB성보 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, SB성보 has recorded 47 public disclosures. Market capitalisation: €5.3bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 윤정선. Every trade is accessible without an account.
Analysts rate SB성보 Buy (bullish), based on 8 analysts. Average price target: €42.88.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 47 declarations
SB성보 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX.